NCT02320916

Brief Summary

Arterial blood-gas (ABG) measurements are the gold standard to evaluate pulmonary gas exchange. However, arterial punctures are more painful than venous punctures and, in ICU patients, cause greater anxiety than tracheal aspiration. The only technique that has been shown to effectively reduce pain during arterial punctures is the subcutaneous injection of lidocaine. However, this technique is more time consuming and is poorly used. Topical anesthesia is widely used during arterial punctures despite the lack of proof of efficacy. While performing arterial punctures with small gauge needles is feasible, to the best of the investigators knowledge no studies have assessed the effect of needle gauge on arterial puncture related pain. The aim of the present study was to compare the pain experienced during arterial punctures performed with a 25 G or 23 G needle. The secondary endpoints were the characterization of the pain and the anxiety associated with the arterial punctures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2013

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2013

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2013

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

December 10, 2014

Completed
9 days until next milestone

First Posted

Study publicly available on registry

December 19, 2014

Completed
Last Updated

August 17, 2016

Status Verified

August 1, 2016

Enrollment Period

1 month

First QC Date

December 10, 2014

Last Update Submit

August 16, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain experienced by the patient during arterial puncture

    Evaluated using a Visual Analogue Scale for pain. Graduated from 0 to 100mm

    Less thant 60minutes after puncture

Secondary Outcomes (3)

  • Anxiety before and after puncture arterial puncture

    Before puncture and less than 60minutes after puncture

  • Most painful moment of the arterial puncture

    Less than 60minutes after puncture

  • Duration of arterial puncture

    10minutes

Study Arms (2)

23Gauge

ACTIVE COMPARATOR

Arterial blood puncture will be performed using a 23Gauge needle

Procedure: 23Gauge

25Gauge

ACTIVE COMPARATOR

Arterial blood puncture will be performed using a 25Gauge needle

Procedure: 25Gauge

Interventions

23GaugePROCEDURE

Arterial puncture will be made using a 23Gauge needle

23Gauge
25GaugePROCEDURE

Arterial puncture will be made using a 25Gauge needle

25Gauge

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients who had a planned assessment of arterial blood gas in our Respiratory Department

You may not qualify if:

  • under the age of 18
  • inability to provide consent
  • the presence of a contraindication to arterial punctures based on the American Association of Respiratory Care Guidelines

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Rouen

Rouen, 76000, France

Location

Related Publications (1)

  • Patout M, Lamia B, Lhuillier E, Molano LC, Viacroze C, Benhamou D, Muir JF, Cuvelier A. A Randomized Controlled Trial on the Effect of Needle Gauge on the Pain and Anxiety Experienced during Radial Arterial Puncture. PLoS One. 2015 Sep 25;10(9):e0139432. doi: 10.1371/journal.pone.0139432. eCollection 2015.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bouchra Lamia, MD, MPH, PhD

    University Hospital, Rouen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2014

First Posted

December 19, 2014

Study Start

April 1, 2013

Primary Completion

May 1, 2013

Study Completion

May 1, 2013

Last Updated

August 17, 2016

Record last verified: 2016-08

Locations